FDA
-
-
-
-
-
-
-
TD Cowen on Dianthus (DNTH): 'the favorable economics of the deal will not impact prior guidance of cash runway into 2028'
-
-
-
-
-
-
-
Dianthus Therapeutics Strengthens Strategic Commercial Leadership With Appointment of John C. King as Chief Commercial Officer and Welcomes Sujay Kango, A Seasoned Commercial Leader, to Board of Direc
-
-
-
-
-
-
322,905 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

